Type IV collagenase expression in human prostate carcinoma cell lines with different metastasis potentials

  • Lin Lin Zhang
  • , Da Lin He
  • , Xiang Li
  • , Lei Li
  • , Guo Dong Zhu
  • , Xin Yang Wang

Research output: Contribution to journalArticlepeer-review

Abstract

OBJECTIVE: To investigate the correlation between type IV collagenase expression and metastatic potential of human prostate carcinoma cells. METHODS: Human prostate carcinoma cell lines (LNCaP and C4-2B) with different metastatic potentials were selected. Using SABC immunocytochemical staining and zymographic analysis, we detected the difference of type IV collagenase expression and activity between the two cell lines. RESULTS: The expression of type IV collagenase (MMP-2, MMP-9) could be detected in both LNCaP and C4-2B, mainly in cytoplasm, much higher in C4-2B than in LNCaP (P < 0.01). The activities of type IV collagenase in the conditioned medium of prostatic carcinoma cell LNCaP was the lowest, and the quantitative estimation values of MMP-2 and MMP-9 were 0.89 +/- 0.02 and 0.86 +/- 0.01, respectively. However, the quantitative estimation values of MMP-2 and MMP-9 in the conditioned medium of C4-2B were 96.32 +/- 4.36 and 33.89 +/- 1.84, respectively. Compared with LNCaP, the activity of type IV collagenase in C4-2B was much higher (P < 0.01). CONCLUSION: Compared with LNCaP, the higher production capability of type IV collagenase in C4-2B may possibly contribute to its invasive and metastatic potentials. The expression of type IV collagenase of human prostate carcinoma cells is closely correlated to the metastatic and invasive potential.

Original languageEnglish
Pages (from-to)913-916
Number of pages4
JournalZhonghua nan ke xue = National journal of andrology
Volume12
Issue number10
StatePublished - Oct 2006
Externally publishedYes

Fingerprint

Dive into the research topics of 'Type IV collagenase expression in human prostate carcinoma cell lines with different metastasis potentials'. Together they form a unique fingerprint.

Cite this